Screener
Kailera Therapeutics KLRA PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Kailera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026.
- Filed
- May 26, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-239417
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 407,348 | 385,789 |
| Prepaid expenses and other current assets | 11,141 | 11,481 |
| Total current assets | 530,315 | 557,537 |
| Property and equipment, net | 1,854 | 1,955 |
| Restricted cash | 761 | 761 |
| Long-term marketable securities | 62,747 | 106,672 |
| Non-current clinical deposits | 13,318 | 12,185 |
| Operating lease right-of-use assets | 10,170 | 10,463 |
Item 1. Financial Statements.
FAQ
- What is Kailera Therapeutics's PP&E (net)?
- Kailera Therapeutics (KLRA) reported PP&E (net) of $1.85M in Q1 2026.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Kailera Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude